Clinical trial · Interventional
Use of Lidocaine in Endoscopic Submucosal Dissection
Effect of Intravenous Lidocaine During Endoscopic Submucosal Dissection for Gastric Neoplasm
NCT02543411CI-TRIAL-00020208completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary purpose of this study is to investigate the effects of lidocaine on the total administered dose of fentanyl during sedation for endoscopic mucosal resection. The secondary purpose of this study is to investigate the effects of lidocaine on pain score related with endoscopic mucosal resection at time of 30 min, 6 hr, and 24 hr after procedure.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Neoplasm | Gastric Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Lidocaine 1% | Drug | — | UNRESOLVED |
| Normal saline | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Lidocaine group
- description
- Administration of lidocaine 1%
- interventionNames
- Drug: Lidocaine 1%
- type
- PLACEBO_COMPARATOR
- label
- Control group
- description
- Administration of normal saline
- interventionNames
- Drug: Normal saline
Primary outcomes (1)
- measure
- Fentanyl consumption during sedation
- timeFrame
- During sedation, an expected average of 40 minutes
Secondary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1\. Endoscopic submucosal dissection for the treatments of early gastric neoplasm Exclusion Criteria: 1. Allergy to lidocaine 2. Chronic pain 3. Chronic abuse of opioid or NSAID 4. Atrioventricular conductance block 5. Liver dysfunction 6. Renal dysfunction
References
Publications (0)
Data not yet available
No reference posted for this study.